Recent 8-K filings for ACU
Highest-materiality recent filing
Acme United Q1 diluted EPS up 39% to $0.39; gross margin expands to 38.7%
- Net sales $45.0M, down 2% YoY; ex-divested lines up 1%. Net income $1.6M, up 65%.
- Diluted EPS $0.39 vs $0.28, a 39% increase. Gross margin 38.7% vs 35.5%.
-
ACME UNITED Corporation Reports Results of 2026 Annual Meeting of Shareholders
All seven director nominees elected: Walter C. Johnsen, Richmond Y. Holden, Brian S. Olschan, Susan H. Murphy, Rex L. Davidson, Brian K. Barker, Paul J. Conway.
-
Acme United Q1 sales up 14% to $52.3M; net income down 40% to $1.0M on tariff costs
Net income $1.0M ($0.24 diluted EPS) vs $1.7M ($0.41) YoY, down 40% and 41% respectively.
-
Acme United Q4 EPS $0.46 (+12% YoY); revenue $47.5M (+3%); acquires My Medic for $18.7M
Q4 net income $1.9M ($0.46 diluted EPS) vs $1.7M ($0.41 EPS) YoY, a 12% increase.
-
Acme United acquires assets of My Medic for $18.7M; My Medic had $19M revenue in 2025
Paid $14.6M cash at closing; up to $4.1M additional based on 2027 revenue milestones and indemnification holdback.
-
Acme United Q3 net sales up 2% to $49.1M; EPS falls 15% to $0.46 on higher tax rate
Net sales $49.1M (+2% YoY); net income $1.9M vs $2.2M (-14%); diluted EPS $0.46 vs $0.54 (-15%).
-
Acme United reports record Q2 net income of $4.8M; sales down 3% to $54.0M
Q2 net income $4.8M ($1.16 diluted EPS), up 7% YoY; record quarterly net income.
-
Acme United extends $65M revolver maturity to May 31, 2027
Amendment No. 11 to Loan Agreement extends maturity of $65M secured revolving credit facility from May 2026 to May 31, 2027.
-
ACME United shareholders reelect all director nominees at 2025 annual meeting
All seven director nominees elected with 2.58M-2.69M votes for each.
-
Acme United Q1 EPS rises 5% to $0.41; net sales up 2% to $46.0M
EPS $0.41 vs $0.39 (+5%); net income $1.65M vs $1.64M (+1%).
-
Acme United replaces auditor Marcum with CBIZ after Marcum's resignation due to acquisition
Marcum LLP resigned as independent auditor on March 24, 2025, following acquisition of its attest business by CBIZ.
-
Acme United Q4 net sales up 10% to $45.9M; FY adj. net income up 23%
Q4 net sales $45.9M (+10% YoY); FY net sales $194.5M (+2% YoY, +6% ex-Camillus/Cuda).
-
Acme United Q3 net income rises 3% to $2.23M despite 4% sales decline
Net income $2.23M ($0.54/diluted) vs $2.15M ($0.58) in Q3 2023; net income up 3%, EPS down 7%.
-
Acme United Q2 net income +29% to $4.5M; acquires Elite First Aid
Q2 net sales $55.4M (+4% YoY; +8% excl. divested Camillus/Cuda lines).
-
Acme United Q2 net income up 29% to $4.5M; EPS $1.09 vs $0.96; revenue $55.4M +4%
Q2 net sales $55.4M (+4% YoY); excluding divested hunting/fishing lines, organic growth 8%.
-
ACME United shareholders re-elect all directors and approve all proposals at annual meeting
Walter C. Johnsen re-elected with 2,284,155 votes for, 17,677 withheld.
-
Acme United Q1 diluted EPS up 39% to $0.39; gross margin expands to 38.7%
Net sales $45.0M, down 2% YoY; ex-divested lines up 1%. Net income $1.6M, up 65%.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.80 · Median 0.65 · Most common event earnings